Abstract
Hypertension is a common disease among the elderly, a population that will continue to grow over the next decade. Untreated hypertension can lead to cardiovascular events and mortality. Given the seriousness of this disease and the increase in the number of elderly with hypertension, this review focuses on the cost of treating hypertension in the elderly as described in recent publications. We found a limited number of articles related to the treatment of hypertension in the elderly. One publication provided insightful information pertaining to expenditures in the United States for hypertension in 1998. This article was the first to examine age distribution among persons 65 years and older. It has been shown that antihypertensive pharmacologic treatment significantly reduces the incidence of cardiovascular events. Without any other medical conditions, thiazide-like diuretics are recommended for the treatment of hypertension in the elderly due to their beneficial effects, low risk for side effects, and low cost. In general, it was found that the elderly have higher expenditures per capita for hypertension and per hypertensive condition.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References and Recommended Reading
Cushman WC, Black HR: Cardiovascular disease in the elderly: hypertension in the elderly. Cardiol Clin 1999, 17:79–92. This article provides an overall review of hypertension (specifically in the elderly). The risks of the disease, the benefits of treatment, and recommendations for treatment are discussed.
The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997, 157:2413–2445.
Dunn EC, Small RE: Economics of antihypertensive therapy in the elderly. Drugs Aging 2001, 18:515–525. This review article takes a look at all the economic considerations that need to be evaluated when determining the cost of antihypertensive treatment in the elderly.
Kaplan NM: Hypertension in the elderly. Ann Rev Med 1995, 45:27–35.
Elliot WJ, Black HR: Treatment of hypertension in the elderly. Am J Geriatr Cardiol 2002, 11:11–21. This article provides an overview of the benefits of treating hypertension, who should be treated, and the treatments of choice for the elderly, all with references to studies.
Moser M, Hebert PR: Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol 1996, 27:1214–1218.
Psaty BM, Smith NL, Siscovick DS, et al.: Health outcomes associated with antihypertensive therapies used as first-line agents: a systematic review and meta-analysis. JAMA 1997, 277:739–745.
Sanchez LA: Pharmacoeconomic principles and methods: an introduction for hospital pharmacists. Hosp Pharm 1994, 29:774–779.
Reeder CE: Overview of pharmacoeconomics and pharmaceutical outcomes evaluations. Am J Health Syst Pharm 1995, 52:S5-S8.
Hodgson TA, Cai L: Medical care expenditures for hypertension, its complications, and its comorbidities. Med Care 2001, 39:599–615. This study evaluated a variety of national data sources to determine national health expenditures for hypertension in 1998. It is the first study to examine the age distribution among persons 65 years of age and older.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Roberts, R.L., Small, R.E. Cost of treating hypertension in the elderly. Current Science Inc 4, 420–423 (2002). https://doi.org/10.1007/s11906-002-0020-7
Issue Date:
DOI: https://doi.org/10.1007/s11906-002-0020-7